According to Horizon Therapeutics 's latest financial reports the company's total liabilities are $3.98 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $4.04 B | 0.93% |
2021-12-31 | $4.00 B | 95.64% |
2020-12-31 | $2.04 B | -9.03% |
2019-12-31 | $2.25 B | -27.22% |
2018-12-31 | $3.09 B | -2.61% |
2017-12-31 | $3.17 B | 4.84% |
2016-12-31 | $3.02 B | 72.67% |
2015-12-31 | $1.75 B | 195.04% |
2014-12-31 | $0.59 B | 97.04% |
2013-12-31 | $0.30 B | 242.79% |
2012-12-31 | $88 M | 59.53% |
2011-12-31 | $55.16 M | -14.64% |
2010-12-31 | $64.62 M | 467.42% |
2009-12-31 | $11.39 M | -51.34% |
2008-12-31 | $23.4 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $137.21 B | 3,340.84% | ๐บ๐ธ USA |
Amgen AMGN | $90.92 B | 2,180.02% | ๐บ๐ธ USA |
Merck MRK | $69.04 B | 1,631.29% | ๐บ๐ธ USA |
AstraZeneca AZN | $61.95 B | 1,453.57% | ๐ฌ๐ง UK |
Dr. Reddy's RDY | $1.26 B | -68.37% | ๐ฎ๐ณ India |